Skip to content

Trump announces that the U.S. has approved the use of the antiviral remdesivir to treat coronavirus patients

May 1, 2020

United States President Donald Trump announced this Friday that U.S. health officials have approved the use of the antiviral drug remdesivir to treat patients with COVID-19, the disease caused by the coronavirus.

Trump made this announcement at a White House appearance with FDA director Stephen Hahn, who made sure the antiviral was available to all approved American COVID-19 patients Hospitals.

The FDA has approved the emergency use of this experimental treatment after some patients treated with remdesivir had a faster recovery from coronavirus infection.

Trump announces that the U.S. has approved the use of the antiviral remdesivir to treat coronavirus patientsTrump announces that the U.S. has approved the use of the antiviral remdesivir to treat coronavirus patients

The FDA made this decision after preliminary results from a Gilead Sciences laboratory study with Redemsivir showed that this antiviral shortened the hospital stay of COVID-19 patients by an average of four days. , according to the CBS television station.

The study was conducted on a sample of 1,063 patients. This was the largest and most rigorous study with this drug and included a comparison group in which patients received the usual treatment without this drug.

Receive Breaking News !

Install
×
Enable Notifications    Ok No thanks